Zota Health Care Limited has submitted to the Exchange, the Audited Financial Results for the quarter and year ended March 31, 2026.
ZOTA · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Zota Health Care Limited has reported strong standalone financial performance for FY 2025-26. Revenue from operations grew 58% to Rs. 40,700.72 lakhs from Rs. 25,727.61 lakhs in the previous year. Standalone profit after tax increased significantly to Rs. 4,075.36 lakhs from Rs. 1,184.33 lakhs, representing 244% growth. The Board also recommended a dividend of Rs. 1 per share (10%) subject to shareholder approval. The auditors issued unmodified opinions on both standalone and consolidated financial statements with no going concern issues. The company approved additional investment of Rs. 16,999.96 lakhs in its wholly-owned subsidiary Davaindia Health Mart Limited. On a consolidated basis, revenue grew 84% to Rs. 53,865.75 lakhs, though the group reported a net loss of Rs. 7,407.74 lakhs due to losses in subsidiaries.
Strong standalone profitability growth and clean audit opinion are positive signals. However, the significant consolidated loss and negative operating cash flows of Rs. 7,295.99 lakhs indicate subsidiary performance remains a concern. Investors should monitor the turnaround of loss-making subsidiaries.